论文信息 - Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. - 字舞流文

Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial.

Hongyang Wang | W. Lau | Zhi-nan Chen | Dong-hao Wu | Chunfang Gao | Jingfeng Liu | Tian Yang | Lu Wu | Yefa Yang | Meng‐chao Wu | Jun Li | Zhen-lin Yan | F. Shen | A. Si | Yong Xia | Kui Wang | Wentao Wang | X. Wan | Jingliang Xing